Prospective Study on Prognosis of Cardiac Resynchronized Therapy (CRT), Implantable Cardioverter Defibrillator (ICD) Implantation in Patients With Congestive Heart Failure (CHF)

November 28, 2019 updated by: Yonsei University
CRT and ICD has known as decreasing cardiac mortality in patient with heart failure. Especially, it has reported that CRT improved cardiac systolic function, quality of life of patients with heart failure. However, CRT and primary ICD was not generalized in Korea. So the investigators will register patients who implant CRT or ICD (primary), and follow them up. During scheduled follow up, all patients will perform echocardiography, 6 minute walking test, EKG, Holter monitoring and questionnaire on QOL.

Study Overview

Status

Recruiting

Intervention / Treatment

Study Type

Observational

Enrollment (Anticipated)

1000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Boyoung Joung, MD, PhD
  • Phone Number: 82-2-2228-8460
  • Email: cby6908@yuhs.ac

Study Locations

      • Seoul, Korea, Republic of, 120-752
        • Recruiting
        • Severance Hospital
        • Contact:
          • Boyoung Joung, MD, PhD
          • Phone Number: 82-2-2228-8460
          • Email: cby6908@yuhs.ac

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

patients with congestive heart failure(including heart failure with preserved EF or reduced EF) who are undergone cardiac resynchronized therapy (CRT), implantable cardioverter defibrillator (ICD) implantation

Description

Inclusion Criteria:

  1. Age >=18
  2. LV ejection fraction <40% or Clinical HF Symptom with (LV ejection fraction >40%)
  3. medication for at least 3month

Exclusion Criteria:

1. patient who refuse to enroll the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
ICD/CRT registry
ICD / CRTregistry in Severance or Ewha Womans University Medical Center
cardiac resynchronized therapy (CRT), implantable cardioverter defibrillator (ICD) implantation

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Transthoracic echocardiography (TTE)
Time Frame: before enrollment
before enrollment
Transthoracic echocardiography (TTE)
Time Frame: 12 month later afer enrollment
12 month later afer enrollment
EKG
Time Frame: before enrollment
for Ventricular arrhythmia events
before enrollment
EKG
Time Frame: 1 month later after enrollment
for Ventricular arrhythmia events
1 month later after enrollment
EKG
Time Frame: 6 month later after enrollment
for Ventricular arrhythmia events
6 month later after enrollment
EKG
Time Frame: 12 month later after enrollment
for Ventricular arrhythmia events
12 month later after enrollment
NYHA(New York Heart Association) evaluation
Time Frame: before enrollment

For functional capacity

- The New York Heart Association (NYHA) Functional Classification provides a simple way of classifying the extent of heart failure. It places patients in one of four categories based on how much they are limited during physical activity; the limitations/symptoms are in regard to normal breathing and varying degrees in shortness of breath and/or angina.

before enrollment
NYHA(New York Heart Association) evaluation
Time Frame: 1 month later after enrollment

For functional capacity

- The New York Heart Association (NYHA) Functional Classification provides a simple way of classifying the extent of heart failure. It places patients in one of four categories based on how much they are limited during physical activity; the limitations/symptoms are in regard to normal breathing and varying degrees in shortness of breath and/or angina.

1 month later after enrollment
NYHA(New York Heart Association) evaluation
Time Frame: 6 month later after enrollment

For functional capacity

- The New York Heart Association (NYHA) Functional Classification provides a simple way of classifying the extent of heart failure. It places patients in one of four categories based on how much they are limited during physical activity; the limitations/symptoms are in regard to normal breathing and varying degrees in shortness of breath and/or angina.

6 month later after enrollment
NYHA(New York Heart Association) evaluation
Time Frame: 12 month later after enrollment

For functional capacity

- The New York Heart Association (NYHA) Functional Classification provides a simple way of classifying the extent of heart failure. It places patients in one of four categories based on how much they are limited during physical activity; the limitations/symptoms are in regard to normal breathing and varying degrees in shortness of breath and/or angina.

12 month later after enrollment
6 minute walking test
Time Frame: before enrollment
for functional capacity
before enrollment
6 minute walking test
Time Frame: 12 month later afer enrollment
for functional capacity
12 month later afer enrollment

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Questionnaire on Quality of Life(QOL) : EQ-5D-3L (Optional)
Time Frame: before enrollment
EQ-5D-3L is the scale used in the health state description part was three-level; having no problems, having some or moderate problems, being unable to do/having extreme problems. Rated level can be coded as a number 1, 2, or 3, which indicates having no problems for 1, having some problems for 2, and having extreme problems for 3. As a result, a person's health status can be defined by a 5-digit number, ranging from 11111 (having no problems in all dimensions) to 33333 (having extreme problems in all dimensions).
before enrollment
Questionnaire on Quality of Life(QOL) : EQ-5D-3L (Optional)
Time Frame: 12 month later afer enrollment
EQ-5D-3L is the scale used in the health state description part was three-level; having no problems, having some or moderate problems, being unable to do/having extreme problems. Rated level can be coded as a number 1, 2, or 3, which indicates having no problems for 1, having some problems for 2, and having extreme problems for 3. As a result, a person's health status can be defined by a 5-digit number, ranging from 11111 (having no problems in all dimensions) to 33333 (having extreme problems in all dimensions).
12 month later afer enrollment
Cardiac MRI or Cardiac CT
Time Frame: before enrollment
before enrollment
Cardiac MRI or Cardiac CT
Time Frame: 12 month later afer enrollment
12 month later afer enrollment

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

April 1, 2014

Primary Completion (Anticipated)

April 1, 2024

Study Completion (Anticipated)

April 1, 2024

Study Registration Dates

First Submitted

May 13, 2014

First Submitted That Met QC Criteria

May 13, 2014

First Posted (Estimate)

May 15, 2014

Study Record Updates

Last Update Posted (Actual)

December 3, 2019

Last Update Submitted That Met QC Criteria

November 28, 2019

Last Verified

November 1, 2019

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 4-2014-0098

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Congestive Heart Failure

Clinical Trials on ICD/CRT

Subscribe